Table 2. Leukemia-free survival (LFS) .... | American Society of Hematology

Table 2.

Leukemia-free survival (LFS)

					LFS rate ± SE, %‡
	Log-rank test^*	Hazard ratio	95% CI†	97.5% CI†	12 mo	24 mo	36 mo
All patients	0.01	0.71	0.54-0.92	0.52-0.96
Control, n = 160					42 ± 3.9	29 ± 3.6	24 ± 3.4
HDC/IL-2, n = 160					48 ± 4.0	41 ± 3.9	34 ± 3.8
Patients in CR1	0.01	0.69	0.51-0.93	0.49-0.97
Control, n = 132					45 ± 4.3	32 ± 4.1	26 ± 3.8
HDC/IL-2, n = 129					52 ± 4.4	45 ± 4.4	40 ± 4.4
Patients in subsequent CR	0.40	0.79	0.43-1.46	0.39-1.60
Control, n = 28					30 ± 8.8	15 ± 6.9	15 ± 6.9
HDC/IL-2, n = 31					29 ± 8.2	23 ± 7.5	10 ± 5.3

					LFS rate ± SE, %‡
	Log-rank test^*	Hazard ratio	95% CI†	97.5% CI†	12 mo	24 mo	36 mo
All patients	0.01	0.71	0.54-0.92	0.52-0.96
Control, n = 160					42 ± 3.9	29 ± 3.6	24 ± 3.4
HDC/IL-2, n = 160					48 ± 4.0	41 ± 3.9	34 ± 3.8
Patients in CR1	0.01	0.69	0.51-0.93	0.49-0.97
Control, n = 132					45 ± 4.3	32 ± 4.1	26 ± 3.8
HDC/IL-2, n = 129					52 ± 4.4	45 ± 4.4	40 ± 4.4
Patients in subsequent CR	0.40	0.79	0.43-1.46	0.39-1.60
Control, n = 28					30 ± 8.8	15 ± 6.9	15 ± 6.9
HDC/IL-2, n = 31					29 ± 8.2	23 ± 7.5	10 ± 5.3

Statistical analysis using the log-rank test, stratified by country and, if applicable, CR stratum.

Confidence intervals for the hazard ratios of the treatment arms.

LFS rates are Kaplan-Meier estimates at each time point.